Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 646 AL 660

The sleeping brain in Parkinson's disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists

Bhidayasiri R, Sringean J, Rattanachaisit W, Truong DD.

J Neurol Sci. 2017 Mar 15;374:32-37. doi: 10.1016/j.jns.2017.01.018. Epub 2017 Jan 7.

Management of impulse control disorders with deep brain stimulation: A double-edged sword

Kasemsuk C, Oyama G, Hattori N.

J Neurol Sci. 2017 Mar 15;374:63-68. doi: 10.1016/j.jns.2017.01.019. Epub 2017 Jan 7.

[Other causes of parkinsonism]

Tranchant C.

Presse Med. 2017 Mar;46(2 Pt 1):210-217. doi: 10.1016/j.lpm.2016.11.008. Epub 2017 Jan 23.

Sterile Neuroinflammation and Strategies for Therapeutic Intervention

Banjara M, Ghosh C.

Int J Inflam. 2017;2017:8385961. doi: 10.1155/2017/8385961. Epub 2017 Jan 3.

Possible effectiveness of low-dose pregabalin in a patient suffering from Lewy body disease and chronic pruritus

Ukai K.

Psychogeriatrics. 2017 Sep;17(5):324-326. doi: 10.1111/psyg.12236. Epub 2017 Jan 28.

Robotic-assisted gait training in Parkinson's disease: a three-month follow-up randomized clinical trial

Furnari A, Calabrò RS, De Cola MC, Bartolo M, Castelli A, Mapelli A, Buttacchio G, Farini E, Bramanti P, Casale R.

Int J Neurosci. 2017 Nov;127(11):996-1004. doi: 10.1080/00207454.2017.1288623. Epub 2017 Feb 13.

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy

Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A.

Neural Plast. 2017;2017:5012129. doi: 10.1155/2017/5012129. Epub 2017 Jan 3.

Algorithms for the treatment of motor problems in Parkinson's disease

Dietrichs E, Odin P.

Acta Neurol Scand. 2017 Nov;136(5):378-385. doi: 10.1111/ane.12733. Epub 2017 Jan 30.

Validation of a Behavioral Approach for Measuring Saccades in Parkinson's Disease

Turner TH, Renfroe JB, Duppstadt-Delambo A, Hinson VK.

J Mot Behav. 2017 Nov-Dec;49(6):657-667. doi: 10.1080/00222895.2016.1250720. Epub 2017 Jan 31.

Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation

Mauri MC, Reggiori A, Paletta S, Di Pace C, Altamura AC.

Expert Opin Drug Saf. 2017 Mar;16(3):365-379. doi: 10.1080/14740338.2017.1288716. Epub 2017 Feb 9.

Developing an innovative online medication calculator for patients with Parkinson's disease who are nil by mouth

Fisher J, Hand A, Jamieson D, Wood B, Walker RW.

Future Hosp J. 2017 Feb;4(1):27-29. doi: 10.7861/futurehosp.4-1-27.

Monitoring training activity during gait-related balance exercise in individuals with Parkinson's disease: a proof-of-concept-study

Conradsson D, Nero H, Löfgren N, Hagströmer M, Franzén E.

BMC Neurol. 2017 Jan 31;17(1):19. doi: 10.1186/s12883-017-0804-7.

Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study

Kimber TE, Fang J, Huddy LJ, Thompson PD.

Intern Med J. 2017 May;47(5):570-573. doi: 10.1111/imj.13378.

Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis

Carbon M, Hsieh CH, Kane JM, Correll CU.

J Clin Psychiatry. 2017 Mar;78(3):e264-e278. doi: 10.4088/JCP.16r10832.

Rasagiline-induced severe recurrent hypoglycemia in a young woman without diabetes: a case report

Ibrahim FA, Rashid F, Hussain AA, Alawadi F, Bashier A.

J Med Case Rep. 2017 Feb 2;11(1):29. doi: 10.1186/s13256-017-1202-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias